ArticleBritish journal of haematology2014

Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002.

David A Rizzieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.